CS for SB 862 - Prescription Drug Monitoring Program

• Establishes a comprehensive electronic database system for tracking controlled substance prescriptions (Schedules II-IV) with reporting requirements from dispensers within 7 days of dispensing.

• Allows law enforcement agencies access to program information only during active investigations under a user agreement that includes annual audits, training requirements, and compliance attestations by agency heads.

• Permits the department to provide patient advisory reports to prescribers and non-identifying information to law enforcement when the program manager determines a pattern exists indicating potential criminal activity.

• Restricts information shared with state attorneys to discovery demands only if directly related to the specific criminal case; unrelated information requires a court order.

• Funds the program with up to $500,000 from the Medical Quality Assurance Trust Fund (pharmacy regulation) and allows federal or private grants, but prohibits funding from prescription drug manufacturers; eliminates the direct support organization mechanism.